Home/Filings/4/0001638599-16-001676
4//SEC Filing

Lipocine Inc. 4

Accession 0001638599-16-001676

$LPCNCIK 0001535955operating

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 10:50 AM ET

Size

5.5 KB

Accession

0001638599-16-001676

Insider Transaction Report

Form 4
Period: 2016-12-07
Mattila Jyrki
Chief Business Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2016-12-07$3.61/sh+40,000$144,40040,000 total
    Exercise: $3.61From: 2017-12-07Exp: 2026-12-07Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 7, 2017, while the remaining 2/3 of the shares subject to the award vesting monthly on a prorata basis over the following two years.

Issuer

Lipocine Inc.

CIK 0001535955

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001535955

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 10:50 AM ET
Size
5.5 KB